 Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators.  Manual de Medicina de Familia - Página 126de Mark A. Graber, Matthew L. Lanternier - 2002 - 968 páginasVista previa restringida - Acerca de este libro
 | Gary Gerstenblith - 2007 - 422 páginas
...of 44 cases. BMJ 2003;327:147-149. 72. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in highrisk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342: 145-153. 73. Yusuf... | |
 | Stephen Geoffrey Ellis, David R. Holmes - 2006 - 566 páginas
...study including 180 post-stroke patients. Thromb Res 1993:71:397-403. 7. Yusuf S, Sleight P, et al. Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl I Med 2000:342:145-153. 8. Eikelboom... | |
 | Luis Bravo, Luis Bravo Díaz - 2005 - 752 páginas
...HEART OUTCOMES PREVENTION EVALUATION STUDY INVESTIGATORS. Effects of an angiotensin-converting-enzymc inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342:145-153. WORLD HEALTH ORGANIZATION-INTERNATIONAL SOCIETY OF HYPERTENSION: GUIDELINESS FOR... | |
 | Alex M. Davison - 2005 - 1156 páginas
...137 (7), 563-570. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., and Dagenais, G. (2000). Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. New England ¡ournal of Medicine 342... | |
 | Walmor C. De Mello - 2005 - 256 páginas
...function after myocardial infarction. Circulation 106, 106-111. Yusuf S, Sleight P, Pogue J, et al. (2000) Effects of an angiotensin-convertingenzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. New England Journal of Medicine 342,... | |
 | Harlan M. Krumholz - 2009 - 284 páginas
...randomized trials. Progress in Cardiovascular Diseases, 1985, Vol. 27,Iss. 5,335—371. Yusuf, S., et al. Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. New England Journal of Medicine, 2000,... | |
 | Girish P. Joshi - 258 páginas
...hypertensive osteoarthritis patients. Am J Ther 200 1 :8:85-95. [126] Yusuf S. Sleight P. Pogue J. et al. Effects of an angiotensin-converting-enzyme inhibitor....cardiovascular events in high-risk patients. N Engl J Med 2000:342: 145-53. [127] ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive... | |
 | Ashley M. Ford - 2006 - 218 páginas
...J. Hypertem. 2002; 20: 1879-1886. [67] The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor,...cardiovascular events in highrisk patients. N. Engl. J. Med. 2000;342:145-153. [68] Mykkanen L, Kuusisto J, Pyorala K, Laakso M, Haffner SM. Increased risk of noninsulin-dependent... | |
 | Steve Hollenberg - 2007 - 182 páginas
...Yusuf S, Sleight P, Pogue J, et al., and The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor,...cardiovascular events in high-risk patients. N Engl J Med 342:145-153,2000. 9 Valvular Diseases AORTIC STENOSIS Etiology and Pathophysiology Aortic stenosis... | |
 | R. Brian Haynes - 2006 - 516 páginas
...N Engl J Med 1986;315:1109-1114. 66. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor,...cardiovascular events in high-risk patients. N Engl I Med 2000:342:145-153. 67. Myers MG, Cairns JA, Singer J. The consent form as a possible cause of... | |
| |
